Trial
NCT06870487
A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Pfizer
Collaborators
—
Condition
Peripheral T Cell Lymphoma
Intervention
PF-08046032
Why stopped
The trial was terminated for strategic business reasons; the decision was not based on any safety and/or efficacy concerns
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-08